{
    "clinical_study": {
        "@rank": "3195", 
        "arm_group": [
            {
                "arm_group_label": "administration of Bronchipret", 
                "arm_group_type": "Experimental", 
                "description": "7 days of administration of Bronchipret, 2 FCT t.i.d"
            }, 
            {
                "arm_group_label": "administration of Sinupret", 
                "arm_group_type": "Experimental", 
                "description": "7 days of administration of Sinupret, 2 CT t.i.d"
            }, 
            {
                "arm_group_label": "administration of Bronchipret Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "7 days of administration of Bronchipret Placebo, 2 FCT t.i.d"
            }, 
            {
                "arm_group_label": "administration of Sinupret Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "7 days of administration of Sinupret Placebo, 2 CT t.i.d"
            }
        ], 
        "brief_summary": {
            "textblock": "Proof of concept: Superiority of Bronchipret or Sinupret to placebo in respect to\n      mucociliary clearance"
        }, 
        "brief_title": "Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Current Smokers", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Volunteers who have given their signed declaration of consent and have signed the\n             data protection declaration\n\n          2. Male or female volunteers 25 - 40 years\n\n          3. Current smokers (5-20 cigarettes per day since 5 years at least)\n\n          4. Ability to taste sweetness of saccharin\n\n          5. Perception of sweetness within 30 minutes after placement of saccharin behind nasal\n             valve\n\n        Exclusion Criteria:\n\n          1. Ciliary dyskinesia\n\n          2. Cystic fibrosis\n\n          3. COPD/emphysema\n\n          4. Asthma\n\n          5. Chronic rhinosinusitis\n\n          6. Acute respiratory tract infection within the last 6 weeks prior to enrolment\n\n          7. Septal or sinus surgery\n\n          8. Symptomatic allergic rhinitis\n\n          9. Known allergic rhinitis\n\n         10. Treatment with not-permitted previous or concomitant therapy\n\n         11. History of snuff consumption for longer than 1 month or intranasal consumption of\n             recreational drugs such as cocaine or heroin for longer than 1 month\n\n         12. Any disease or condition that might affect the safety of the subject during the\n             trial, according to the investigator's judgement"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01928901", 
            "org_study_id": "Saccharin test"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "administration of Sinupret", 
                    "administration of Sinupret Placebo"
                ], 
                "intervention_name": "administration of Sinupret", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "administration of Bronchipret", 
                    "administration of Bronchipret Placebo"
                ], 
                "intervention_name": "administration of Bronchipret", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "administration of Sinupret", 
                    "administration of Sinupret Placebo"
                ], 
                "intervention_name": "administration of Sinupret Placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "administration of Bronchipret", 
                    "administration of Bronchipret Placebo"
                ], 
                "intervention_name": "administration of Bronchipret Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "contact": {
                "email": "Claus.Bachert@UGent.be", 
                "last_name": "Claus Bachert, Prof. Dr. Dr."
            }, 
            "facility": {
                "address": {
                    "city": "Ghent", 
                    "country": "Belgium", 
                    "zip": "9000"
                }, 
                "name": "University Hospital Ghent"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "4", 
        "official_title": "Randomized, Placebo-controlled, Double-blind, Cross-over Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)", 
        "overall_contact": {
            "email": "gudrun.werner@bionorica.de", 
            "last_name": "Gudrun Werner", 
            "phone": "0049 9181231273"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Ghent", 
            "last_name": "Claus Bachert, Prof.Dr.Dr.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time to perception of sweetness after 7 days of treatment with the investigational products - relative to the time to perception of sweetness at the begin-ning of treatment", 
            "measure": "Time to perception of sweetness", 
            "safety_issue": "No", 
            "time_frame": "after 7 days of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01928901"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To measure the time to perception of sweetness of Saccharin after 7 days of treatment with the investigational products calculated as difference to time to perception of sweetness at the beginning of treatment. The time of sweetness will be measured in minutes and seconds.", 
            "measure": "Perception of Sweetness of Saccharin", 
            "safety_issue": "No", 
            "time_frame": "4 - 7 weeks"
        }, 
        "source": "Bionorica SE", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bionorica SE", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}